Why don't we have phage therapy yet? We want to understand why. On the Podovirus podcast, we interview people we think could

Why don't we have phage therapy yet? We want to understand why. On the Podovirus podcast, we interview people we think could have the answers.

🎙️ Most recent episode: Joe and Jessica interviewed Dr. Saima Aslam, clinical lead at IPATH about how her approach has evolved since 2017, why patient selection has become crucial, and the importance of phage researcher-clinician collaboration for designing trials that actually work.

🎧 Listen: Podovirus on Spotify

🎥 Watch: Podovirus on YouTube

Subscribe to Podovirus to get the next episodes.

💰 On deck: Next up, we'll release our interview with Ross Rheingans-Yoo. He's a biotech investor who thinks phage therapy and other personalized medicine fields could work if done differently. What would it take to make the economics work? How does he see the phage field, and how does he compare it to other medicines he's considering investing in?